Urticaria Facticia Treatment With Omalizumab (UFO)

计划入组 61 人 · 首次发布于 2014 年 6 月 20 日

A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of CDX-0159 in Patients With Cold Contact Urticaria, Symptomatic Dermographism, or Cholinergic Urticaria

计划入组 41 人 · 首次发布于 2020 年 9 月 16 日

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

计划入组 240 人 · 首次发布于 2025 年 12 月 5 日

GalNAc-conjugated siRNA therapeutic (non-symptomatic cirrhosis)

Cytidine-5'-Monophosphate

C₉H₁₄N₃O₈P

Benzydamine(Pharixia, Tantum)

C₁₉H₂₃N₃O

Celldex Advances Barzolvolimab into Phase 3 Trials for Cold Urticaria and Symptomatic Dermographism

Barzolvolimab Shows Promise in Phase II Trial for Chronic Inducible Urticaria

Barzolvolimab Achieves Primary and Secondary Endpoints in Chronic Inducible Urticaria Phase 2 Trial